Market Research Future

Human Vaccine Market Is Expected to Grow at a CAGR of 11.8% by 2022

Human Vaccines Market which was $ 2.8 billion in 2015 to reach around $ 5.46 billion in future, growing at a CAGR of 11.8% | Human Vaccines Market

 

Pune, Maharashtra -- (SBWIRE) -- 04/27/2017 -- Market Highlights

A vaccine contains a biological preparation of a weakened or killed microbial agent, its toxins or its surface proteins, which provides active acquired immunity against the disease caused by the microbe. Vaccination stimulates and trains the body immunity to recognize and destroy the microbial threat in later encounters. According to World Health Organization (WHO), out of the total number of children worldwide who did not receive the required three doses of diphtheria-tetanus-pertussis vaccines, more than 40% were from sub-Saharan Africa. Sub Saharan Africa accounts for a bulk share of unimmunized people in Africa. The other African nations with large number of unimmunized people include Nigeria, Iraq, Chad, Niger, Angola, Somalia, Sudan, Democratic Republic of Congo, Ethiopia, Iraq, Nigeria, Uganda and South Africa.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2671

The market for vaccines in Middle East and Africa presents immense potential. The market driving factors are unmet needs for vaccination, policies of national Governments and international bodies such as World Health Organization (WHO) which provide huge funding and international aid, increasing funds from philanthropy organizations such as Bill and Melinda Gates Foundation, inclusion of several new vaccines in the national immunization schedule of many countries, development of new vaccines such as for hepatitis; growing awareness, growth of low cost vaccine manufacturing especially in developing countries, the entry of China in the vaccine market etc.

Key Players

The major participants of this market are: GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech, Shenzhen Kangtai Biological Products, Valeant Pharmaceuticals, Emergent Biosolutions Inc., Astellas Pharma Inc., Panacea Biotec and others.

Regional Analysis:

Depending on geographic region, human vaccine market is segmented into following countries: UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman. UAE is the largest market followed by Egypt. However the future market will be led by the poor developed parts of Africa due to large unmet needs and the favorable government policies.

Segmentation:

Middle East and Africa human vaccines market has been segmented on the basis of technology commonly mentioned as "by technology" which comprises attenuated, inactivated, toxoid, conjugate, & subunit, recombinant DNA. On the basis of disease indication the market is segmented into pneumococcal, influenza, hepatitis, rotavirus, DTP, polio and others. On the basis of type market is segmented into prophylactic and therapeutic. On the basis of composition the market is again segmented into mono vaccine and combination vaccines. On the basis of route of administration; market is segmented into oral, injectable and other. On the basis of end user; market is segmented into children and adults.

Browse full Human Vaccines Market @ https://www.marketresearchfuture.com/reports/human-vaccines-market-2671

Taste the market data and market information presented in more than 60 market data tables and figures spread over 84 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on "The Middle East and Africa Human Vaccine Market Research Report - Forecast to 2022".

Table of Content
1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
4.1 Porter's Five Forces Model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor's
4.1.4 Threat of New Entrants
5 Middle East and Africa Human Vaccines Market, by Technology
6 Middle East and Africa Human Vaccines Market, by Disease Indication
7 Middle East and Africa Human Vaccines Market, by Type
7.1 Introduction
7.1.1 Prophylactic
7.1.2 Therapeutic
8 Middle East and Africa Human Vaccines Market, by Composition
8.1 Introduction
8.1.1 Mono vaccine and
8.1.2 Combination vaccines
9 Middle East and Africa Human Vaccines Market, by Route of Administration
9.1 Introduction
9.1.1 Oral
9.1.2 Injectible
9.1.3 Others
10 Middle East and Africa Human Vaccines Market, by End User

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.